Telapristone acetate, an orally-available, selective progesterone receptor modulator, is in development to alleviate symptoms associated with both uterine fibroids and endometriosis.
For the treatment of uterine fibroids and endometriosis.
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.